•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

J01644 Summary:

BILL NOJ01644
 
SAME ASNo Same As
 
SPONSORMURRAY
 
COSPNSR
 
MLTSPNSR
 
 
Go to top

J01644 Text:

 
Senate Resolution No. 1644
 
BY: Senator MURRAY
 
        MEMORIALIZING  Governor  Kathy  Hochul to proclaim
        July 2026, as MECP2 Duplication  Syndrome  Awareness
        Month in the State of New York
 
  WHEREAS, MECP2 duplication syndrome is usually caused by duplication
of DNA on the Xq28 region of the chromosomes; and
 
  WHEREAS,    Despite    MECP2    duplication   syndrome's   being   a
neurodevelopmental disorder, it causes  multisystemic  health  problems,
such   as   severe   gastrointestinal   symptoms,  frequent  respiratory
infections, and treatment-resistant seizures; and
 
  WHEREAS, Some individuals have large duplications which include many
other genes, and the full extent of phenotypes, due  to  duplication  of
other genes, is not completely understood at this time; and
 
  WHEREAS,  Recent studies have shown a link between MECP2 duplication
syndrome and autism, and  many  with  this  syndrome  do  have  distinct
features of autism; and
 
  WHEREAS,   Patients  with  MECP2  duplication  syndrome  are  highly
responsive to proper stimulation such  as  education,  exercise,  music,
age-appropriate social interactions, and related activities; and
 
  WHEREAS,  MECP2  duplication syndrome can cause significant anxiety,
depression, and emotional exhaustion for caregivers; and
 
  WHEREAS, MECP2 duplication  syndrome  was  not  formally  recognized
until 2005; and
 
  WHEREAS,  MECP2  duplication syndrome research, which has shown that
symptoms of the  disorder  can  be  reversed  in  mice,  using  a  small
anti-sense  oligonucleotide,  gives  hope  for the future development of
effective treatments for humans with this disorder; and
 
  WHEREAS, Clinical readiness studies have been done to identify  ways
to  monitor  response  to therapy and ensure safety as a preparation for
future clinical trials; and
 
  WHEREAS, Natural history studies are ongoing to define  the  natural
course  of  MECP2  duplication syndrome over the span of 12-18 months to
prepare for the start of clinical trials; now, therefore, be it
 
  RESOLVED, That this Legislative Body pause in its  deliberations  to
memorialize  Governor  Kathy  Hochul  to  proclaim  July  2026, as MECP2
Duplication Syndrome Awareness Month in the State of New York; and be it
further
 
  RESOLVED, That a copy of this  Resolution,  suitably  engrossed,  be
transmitted  to The Honorable Kathy Hochul, Governor of the State of New
York.
Go to top